Pieris Pharmaceuticals, Inc. (PIRS) Social Stream
PIERIS PHARMACEUTICALS INC (PIRS) Price Targets From Analysts
Use the tables below to see what analysts covering PIERIS PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-02 | 3 | $9 | $8 | $8.5 | $0.176 | 4729.55% |
| 2022-05-11 | 2 | $8 | $8 | $8 | $0.176 | 4445.45% |
| 2023-03-29 | 2 | $7 | $7 | $7 | $0.176 | 3877.27% |
The Trend in the Analyst Price Target
Over the past 21 months, PIRS's average price target has gone down $1.5.
500 - Internal server error
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-29 | 2 | 7 | 7 | 7 | 1.06 | 560.38% |
PIRS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 17 months, PIRS's average broker recommendation rating improved by 0.5.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how PIERIS PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 298.65% of that group.
- PIERIS PHARMACEUTICALS INC's variance in analysts' estimates is lower than 95.36% of Business Services stocks.
- In the context of Business Services stocks, PIERIS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 9.36% of them.
- In the context of Business Services stocks, PIERIS PHARMACEUTICALS INC's average analyst price target is greater than 24.94% of them.
Stocks similar to PIERIS PHARMACEUTICALS INC in the Business Services industry regarding analyst recommendations and price targets are LUNA, NRC, and SNCE.
View All Top Stocks by Price Target
Make investment decisions regarding PIRS using the data that counts. Try POWR Ratings for free.